Product pipeline

from Wikipedia, the free encyclopedia

Under the product pipeline of a company is the amount of new products that are still in development are. In the pharmaceutical and biotechnology industry in particular , it is an important indicator of innovative ability and corporate success and is taken into account when evaluating companies. The creation of a “full product pipeline” ensures the company's profitability and ability to grow.

A pipeline is actually a pipe that has something flowing in at one end and something flowing out at the other. This symbolizes the ongoing progress of the products from the beginning of development to market readiness : At various points in the pipeline, products are in a comparable development stage.

Often the development time for individual products cannot be (precisely) planned. Therefore, they do not always move first in - first out through the imaginary pipeline, but can overtake other products or fall behind on schedule, so that the order of the market launch deviates from the order of the project start.

A “well-filled product pipeline” is a common PR term and can increase the market value of a company.

Other meanings

In the petrochemical industry is meant by a product pipeline or product pipeline , a pipeline that transports already processed products such as gasoline or diesel.

Individual evidence

  1. Hans-Werner G. Grunow, Stefanus Figgener: Handbuch Moderne Unternehmensfinanzierung , Springer 2006, page 59.
  2. Markus Raueiser: The Biotechnology Cluster in the Northern European Growth Area , Kölner Wissenschaftsverlag 2005, page 24.
  3. ^ Simon Grand, Daniel Bartl: Executive Management in Practice , Campus Verlag 2011, page 169
  4. Hagen Puschmann: Models of Risk-Adjusted Pipeline Assessment at Pharmaceutical and Biotech Companies - Presentation and Evaluation , GRIN Verlag 2007.
  5. Dieter Gramlich, Manfred Träger: Challenges of a future-oriented corporate policy , Springer 2007, page 214.
  6. Reavis Mary Hilz-Ward, Oliver Everling: Risk Performance Management , Springer 2009, page 254.
  7. Klaus Gaedke, Martin Nöstlthaller-Kropf, Gerold Pinter: Innovative Financing & Investments , dbv Fachverlag für Steuer- und Wirtschaftsrecht 2012, page 218.
  8. Pharma stocks: Product pipeline - the second price risk on manager-magazin.de (accessed on May 15, 2014)
  9. ^ Thomas Heidorn: Finanzmathematik in der Bankpraxis , Springer 2009, page 120.
  10. Harald Gleissner, J. Christian Femerling, Logistik , Springer 2007, page 65.
  11. ^ NN: Container Conference 1969: Papers and contributions to the discussion , Study Society for Combined Transport 1969, p. 24.